How Glucose Monitors Affect Healthcare Spending
1 month ago - By Managed Healthcare Executive
Continuous glucose monitors offer benefits to type 1 diabetes patients, such as measuring glucose in real time, but can be costly.
However, a new study , published April 12, 2018 in Diabetes Care , from the American Diabetes Association, found that continuous glucose monitoring is very cost-effective for patients with type 1 diabetes that use multiple daily injections.
“The device does increase healthcare costs but this is offset by the prevention of future costly complications,” says senior study author Elbert Huang, MD, associate director of the Chicago Center for Diabetes...
Read more ...
Search by Tags
Senior Regard Injections Diabetes Injection American Diabetes Association Blood sugar Blood sugar control Business Strategy CGM Chicago Center for Diabetes Translation Research Chronic disease management Chronic diseases Continuous glucose monitoring Diabetes Finger prick method Glucose Health Management Health Disease Strategy Hypoglycemia Insulin Insulin pumps Medical device Medicare MHE Articles Technology Triple Aim Type 1 diabetes University of Chicago
The headlines of Master Doctor
Blood test for prostate cancer could eliminate the need for almost half of...
US researchers have come up with a potential replacement for the unreliable PSA blood test currently used on the NHS in Britain, which can be wrong three out of four times.
Interventions That May Slow Memory Loss in Early Alzheimer's Disease
While research remains ongoing into Alzheimer's and other cognitive diseases, doctors and medical researchers do know that early detection is key to being able to provide what...
Forced into early menopause, now I can't stay slim: MATT ROBERTS answers...
If you are overweight, losing the excess pounds is known to help ease some common menopausal symptoms such as exhaustion and hot flushes.
Finasteride Does Not Increase Risk of Prostate Cancer Death
Finasteride, a common hormone-blocking drug, reduces men's risk of getting prostate cancer without increasing their risk of dying from the disease, revealed research.
More Than 40 Percent of Prostate Biopsies Could be Avoided With New Blood Test
IsoPSA - a new blood test has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen .
New Data: Finasteride Safely Prevents Prostate Cancer
The thumbnail take on finasteride has been that it prevents prostate cancer but increases the risk for high-grade disease. A new study debunks the latter idea. Medscape Medical...
'Notable Differences' With 3 Prostate Cancer Genomics Tests
In a novel study, the three leading prostate cancer genomics tests, which are used to help stratify favorable-risk cancers and to aid decision-making about active surveillance...
Osteoporosis in patients with intestinal insufficiency and intestinal...
Intestinal insufficiency and intestinal failure are associated with malabsorption of micro- and macronutrients that may negatively influence bone metabolism and increase the...
Assay May Help Avoid Needless Prostate Biopsies
Distinguishes clinically significant from insignificant/benign disease
Proposed Guidelines Target Opioid Overprescribing in Urology
After finding that many of the opioid tablets prescribed by urologists go unused, researchers propose new prescription standards for urologic procedures. Medscape Medical News